Free Trial

Deutsche Bank AG Increases Stock Holdings in Owens & Minor, Inc. (NYSE:OMI)

Owens & Minor logo with Medical background

Deutsche Bank AG grew its position in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 77.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 495,111 shares of the company's stock after purchasing an additional 215,455 shares during the quarter. Deutsche Bank AG owned about 0.64% of Owens & Minor worth $6,471,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in OMI. Freestone Grove Partners LP bought a new position in Owens & Minor during the 4th quarter worth approximately $5,125,000. Charles Schwab Investment Management Inc. raised its holdings in Owens & Minor by 13.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company's stock worth $30,127,000 after purchasing an additional 276,807 shares during the last quarter. Norges Bank bought a new position in Owens & Minor during the 4th quarter worth approximately $2,465,000. Kennedy Capital Management LLC raised its holdings in Owens & Minor by 15.5% during the 4th quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company's stock worth $15,904,000 after purchasing an additional 163,184 shares during the last quarter. Finally, Gabelli Funds LLC raised its holdings in Owens & Minor by 81.1% during the 4th quarter. Gabelli Funds LLC now owns 326,000 shares of the company's stock worth $4,261,000 after purchasing an additional 146,000 shares during the last quarter. Institutional investors own 98.04% of the company's stock.

Insider Buying and Selling at Owens & Minor

In other news, major shareholder Coliseum Capital Management, L purchased 1,738,511 shares of the stock in a transaction dated Friday, February 28th. The shares were purchased at an average cost of $9.39 per share, with a total value of $16,324,618.29. Following the completion of the acquisition, the insider now owns 9,469,698 shares in the company, valued at $88,920,464.22. This represents a 22.49% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders have acquired a total of 2,718,412 shares of company stock valued at $24,495,308 over the last three months. 3.69% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on OMI. JPMorgan Chase & Co. lowered their price target on shares of Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. Citigroup lowered their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. UBS Group lowered their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Robert W. Baird lifted their price objective on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $12.50.

View Our Latest Stock Report on Owens & Minor

Owens & Minor Stock Performance

NYSE OMI traded down $0.43 during trading on Friday, hitting $6.45. 1,127,347 shares of the company's stock traded hands, compared to its average volume of 1,135,813. The stock has a market capitalization of $498.29 million, a price-to-earnings ratio of -9.92, a PEG ratio of 0.20 and a beta of 1.38. Owens & Minor, Inc. has a 12-month low of $6.07 and a 12-month high of $17.78. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The business has a 50 day moving average of $7.61 and a 200-day moving average of $10.40.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Saturday, May 10th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.20 by $0.03. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.19 EPS. As a group, equities research analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Owens & Minor announced that its Board of Directors has initiated a share repurchase program on Friday, February 28th that permits the company to repurchase $100.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 13.6% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

Owens & Minor Profile

(Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Recommended Stories

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines